Hybrids of Benzimidazole-oxadiazole: A New Avenue for Synthesis, Pharmacological Activity and Recent Patents for the Development of More Effective Ligands

Overview

Journal Curr Org Synth

Publisher Bentham Science Publishers

Specialty Chemistry

Date 2023 Nov 2

PMID 37916627

Authors

Gunjan Bhasker

Salahuddin

Avijit Mazumder

Rajnish Kumar

Greesh Kumar

Mohamed Jawed Ahsan

Mohammad Shahar Yar

Fahad Khan

Bhupinder Kapoor

Affiliations

Soon will be listed here.

Abstract

Background: Two significant families of compounds i.e. 1,3,4-oxadiazole and benzimidazole, have undergone extensive investigation into their pharmacological characteristics and possible therapeutic applications. Both classes have shown their potential in a variety of applications, and because of their synergistic interactions, they may have an even better therapeutic impact when combined.

Objectives: To produce a specific molecule with potent therapeutic properties, it is now common methods to combine at least two pharmacophores. This facilitates interaction with several targets, enhances biological functions, or eliminates adverse effects associated with them.

Conclusion: The synthesis of benzimidazole-1,3,4-oxadiazole hybrid compounds has recently involved the use of several synthetic techniques, all of which are detailed in the literature along with the advantages and disadvantages. It has been noted that the structure-activity relationship relates their pharmacological actions to their molecular structure. In order to set the stage for future research, the study aims to provide researchers with an effective toolbox and an understanding of benzimidazole and 1,3,4-oxadiazole hybrid compounds.

References

Yadav G, Ganguly S . Structure activity relationship (SAR) study of benzimidazole scaffold for different biological activities: A mini-review. Eur J Med Chem. 2014; 97:419-43. DOI: 10.1016/j.ejmech.2014.11.053. View

Sundaraganesan N, Ilakiamani S, Subramani P, Joshua B . Comparison of experimental and ab initio HF and DFT vibrational spectra of benzimidazole. Spectrochim Acta A Mol Biomol Spectrosc. 2006; 67(3-4):628-35. DOI: 10.1016/j.saa.2006.08.020. View

Shrivastava N, Naim M, Alam M, Nawaz F, Ahmed S, Alam O . Benzimidazole Scaffold as Anticancer Agent: Synthetic Approaches and Structure-Activity Relationship. Arch Pharm (Weinheim). 2017; 350(6). DOI: 10.1002/ardp.201700040. View

Fei F, Zhou Z . New substituted benzimidazole derivatives: a patent review (2010 - 2012). Expert Opin Ther Pat. 2013; 23(9):1157-79. DOI: 10.1517/13543776.2013.800857. View

Tahlan S, Kumar S, Kakkar S, Narasimhan B . Benzimidazole scaffolds as promising antiproliferative agents: a review. BMC Chem. 2019; 13(1):66. PMC: 6661752. DOI: 10.1186/s13065-019-0579-6. View

Jerez G, Kaufman G, Prystai M, Schenkeveld S, Donkor K . Determination of thermodynamic pKa values of benzimidazole and benzimidazole derivatives by capillary electrophoresis. J Sep Sci. 2009; 32(7):1087-95. DOI: 10.1002/jssc.200800482. View

Lubega G, Prichard R . Specific interaction of benzimidazole anthelmintics with tubulin: high-affinity binding and benzimidazole resistance in Haemonchus contortus. Mol Biochem Parasitol. 1990; 38(2):221-32. DOI: 10.1016/0166-6851(90)90025-h. View

Tuncbilek M, Kiper T, Altanlar N . Synthesis and in vitro antimicrobial activity of some novel substituted benzimidazole derivatives having potent activity against MRSA. Eur J Med Chem. 2008; 44(3):1024-33. DOI: 10.1016/j.ejmech.2008.06.026. View

Kucukbay H, Uckun M, Apohan E, Yesilada O . Cytotoxic and antimicrobial potential of benzimidazole derivatives. Arch Pharm (Weinheim). 2021; 354(8):e2100076. DOI: 10.1002/ardp.202100076. View

10.

Elnima E, Zubair M, Al-Badr A . Antibacterial and antifungal activities of benzimidazole and benzoxazole derivatives. Antimicrob Agents Chemother. 1981; 19(1):29-32. PMC: 181352. DOI: 10.1128/AAC.19.1.29. View

11.

Paul K, Bindal S, Luxami V . Synthesis of new conjugated coumarin-benzimidazole hybrids and their anticancer activity. Bioorg Med Chem Lett. 2013; 23(12):3667-72. DOI: 10.1016/j.bmcl.2012.12.071. View

12.

Zhang S, Damu G, Zhang L, Geng R, Zhou C . Synthesis and biological evaluation of novel benzimidazole derivatives and their binding behavior with bovine serum albumin. Eur J Med Chem. 2012; 55:164-75. DOI: 10.1016/j.ejmech.2012.07.015. View

13.

Lanusse C, Prichard R . Clinical pharmacokinetics and metabolism of benzimidazole anthelmintics in ruminants. Drug Metab Rev. 1993; 25(3):235-79. DOI: 10.3109/03602539308993977. View

14.

Sadek B, Fahelelbom K . Synthesis, characterization, and antimicrobial evaluation of oxadiazole congeners. Molecules. 2011; 16(6):4339-47. PMC: 6264570. DOI: 10.3390/molecules16064339. View

15.

Bostrom J, Hogner A, Llinas A, Wellner E, Plowright A . Oxadiazoles in medicinal chemistry. J Med Chem. 2011; 55(5):1817-30. DOI: 10.1021/jm2013248. View

16.

Chitambar C, Wereley J . Resistance to the antitumor agent gallium nitrate in human leukemic cells is associated with decreased gallium/iron uptake, increased activity of iron regulatory protein-1, and decreased ferritin production. J Biol Chem. 1997; 272(18):12151-7. DOI: 10.1074/jbc.272.18.12151. View

17.

Singh P, Sharma P, Sharma J, Upadhyay A, Kumar N . Synthesis and evaluation of substituted diphenyl-1,3,4-oxadiazole derivatives for central nervous system depressant activity. Org Med Chem Lett. 2012; 2(1):8. PMC: 3306192. DOI: 10.1186/2191-2858-2-8. View

18.

Glomb T, Szymankiewicz K, Swiatek P . Anti-Cancer Activity of Derivatives of 1,3,4-Oxadiazole. Molecules. 2018; 23(12). PMC: 6320996. DOI: 10.3390/molecules23123361. View

19.

Hendawy O . A comprehensive review of recent advances in the biological activities of 1,2,4-oxadiazoles. Arch Pharm (Weinheim). 2022; 355(7):e2200045. DOI: 10.1002/ardp.202200045. View

20.

Khalilullah H, Ahsan M, Hedaitullah M, Khan S, Ahmed B . 1,3,4-oxadiazole: a biologically active scaffold. Mini Rev Med Chem. 2012; 12(8):789-801. DOI: 10.2174/138955712801264800. View